(2R,3R,4S,5R)-2-(6-Amino-8-(dimethylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

ID: ALA3823299

PubChem CID: 6932036

Max Phase: Preclinical

Molecular Formula: C12H18N6O4

Molecular Weight: 310.31

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1nc2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C12H18N6O4/c1-17(2)12-16-6-9(13)14-4-15-10(6)18(12)11-8(21)7(20)5(3-19)22-11/h4-5,7-8,11,19-21H,3H2,1-2H3,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1

Standard InChI Key:  ASFQZUKBYFITHP-IOSLPCCCSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
    6.1003   -4.6309    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0501   -5.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7662   -4.4393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3840   -5.0218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1111   -6.1904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4028   -3.8873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2065   -3.9814    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1852   -2.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6393   -2.9446    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9991    2.7132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0872    0.0382    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6738    1.0851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7008   -0.9930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  1
  4  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  1  0
  3  9  1  0
  8 10  1  6
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 13 19  2  0
 10 19  1  0
 11 20  1  0
 20 21  1  0
 20 22  1  0
M  END

Associated Targets(Human)

HSPA8 Tchem Heat shock cognate 71 kDa protein (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 310.31Molecular Weight (Monoisotopic): 310.1390AlogP: -1.91#Rotatable Bonds: 3
Polar Surface Area: 142.78Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.45CX Basic pKa: 4.46CX LogP: -1.30CX LogD: -1.30
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.51Np Likeness Score: 0.65

References

1. Cheeseman MD, Westwood IM, Barbeau O, Rowlands M, Dobson S, Jones AM, Jeganathan F, Burke R, Kadi N, Workman P, Collins I, van Montfort RL, Jones K..  (2016)  Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.,  59  (10): [PMID:27119979] [10.1021/acs.jmedchem.5b02001]
2. Li, Xiaokai and 8 more authors.  2013-11-14  Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents.  [PMID:24312699]
3. Cheeseman, Matthew D and 12 more authors.  2016-05-26  Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.  [PMID:27119979]
4. Shao, Hao and 12 more authors.  2018-07-26  Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).  [PMID:29953808]

Source